Mitigating risks of the Opioid Therapy Program
Pharmacists have admirably navigated the changes to the provision of the Opioid Therapy Program (OTP) in 2023, overcoming numerous challenges whilst maintaining uninterrupted service to
Pharmacists have admirably navigated the changes to the provision of the Opioid Therapy Program (OTP) in 2023, overcoming numerous challenges whilst maintaining uninterrupted service to
In recent years, the pharmacy profession has seen significant expansion in the range of medicines that pharmacists can administer by injection. The scope has broadened
With the availability of the latest Pfizer (COMIRNATY®) Omicron XBB.1.5 vaccine, indicated for 12 years and over, there may be potential for selection or administration
The prescribing and supply of medicinal cannabis is a rapidly expanding area of practice in Australia. With this emerging field comes the need for comprehensive
The PDL Professional Officers often manage calls, incident reports and occasional regulatory complaints following a pharmacist’s decision to decline supply of a medication. Recently, the
PDL is raising awareness with hospital pharmacists about the need to report incidents to PDL. This call has been prompted by a recent review of
Pharmacists are at the forefront of patient care, ensuring the safe and effective use of medications. Despite pharmacists best efforts, incidents can result in complaints,
Meridian Lawyers issue state and territory-specific guides It’s OK to say sorry. Pharmacists are human beings and fallible, so despite their best efforts, adverse events
Professional Indemnity insurance (PI insurance or PII) may seem like an uninteresting topic, however, the relevance becomes very clear if there is action taken against
PDL currently supports around 30,000 members across Australia. Hundreds of incident reports are received each year and members have access to numerous resources to assist